Skip to Main Content

Author Details

Michele Ceribelli
National Center for Advancing Translational Sciences
2004
44
27
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36883564mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer.JCI Insight2023
37858338High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma.Cell Rep Med2023
37627061Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma.Cancers (Basel)2023
37216280Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication.Mol Cancer Ther2023
37348462Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomics.Cell Syst2023
37380628A landscape of response to drug combinations in non-small cell lung cancer.Nat Commun2023
37141112Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas.Cancer Discov2023
37140427CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations.Cancer Res2023
34624079SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma.Blood2022
35754026Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma.J Exp Clin Cancer Res2022
36192480Publisher Correction: Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma.Nat Commun2022
36115844Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma.Nat Commun2022
33271120Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas.Immunity2021
33848478Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress.Cancer Cell2021
34778802Overcoming Acquired Epigenetic Resistance to BTK Inhibitors.Blood Cancer Discov2021
34767771Topoisomerase 1 activity during mitotic transcription favors the transition from mitosis to G1.Mol Cell2021
34296206KiRNet: Kinase-centered network propagation of pharmacological screen results.Cell Rep Methods2021
31748226Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening.Sci Transl Med2019
30057145Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.Cancer Cell2018
29925955A multiprotein supercomplex controlling oncogenic signalling in lymphoma.Nature2018
27986456Isoform-Specific Expression and Feedback Regulation of E Protein TCF4 Control Dendritic Cell Lineage Specification.Immunity2017
28899971Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma.Clin Cancer Res2017
28552327Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.Cancer Cell2017
27070702Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma.Cancer Cell2016
27846392A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm.Cancer Cell2016
27799566Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma.Proc Natl Acad Sci U S A2016
26231120Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells.Immunity2015
24155397Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells.J Virol2014
24980046ETO family protein Mtg16 regulates the balance of dendritic cell subsets by repressing Id2.J Exp Med2014
25049379Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors.Proc Natl Acad Sci U S A2014
24492847Oncogenic mechanisms in Burkitt lymphoma.Cold Spring Harb Perspect Med2014
24491438Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms.Cancer Discov2014
23431138Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma.Proc Natl Acad Sci U S A2013
24101375Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells.J Exp Med2013
22885699Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.Nature2012
22698399Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma.Cancer Cell2012
21934679Malignant pirates of the immune system.Nat Immunol2011
19690168NF-YC complexity is generated by dual promoters and alternative splicing.J Biol Chem2009
18446193An NF-Y-dependent switch of positive and negative histone methyl marks on CCAAT promoters.PLoS One2008
18212061The histone-like NF-Y is a bifunctional transcription factor.Mol Cell Biol2008
17003378The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes.Blood2007
16721047Repression of new p53 targets revealed by ChIP on chip experiments.Cell Cycle2006
15961672Selective effects of the anticancer drug Yondelis (ET-743) on cell-cycle promoters.Mol Pharmacol2005
15459184NF-Y regulates the antisense promoter, bidirectional silencing, and differential epigenetic marks of the Kcnq1 imprinting control region.J Biol Chem2004
  • 1 - 44 of 44

Recommended Authors

McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 5
Texas Children's Cancer Center
Career Start Year 2010
Number of shared co-authors 1
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 5
Emory University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Columbia University
Career Start Year 2009
Number of shared co-authors 4
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
The Francis Crick Institute
Career Start Year 2008
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 6
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 1
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 1
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 1
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 9
Max Planck Institute for Molecular Genetics
Career Start Year 2002
Number of shared co-authors 0
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 4
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 0
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2001
Number of shared co-authors 1
Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
Career Start Year 2000
Number of shared co-authors 4
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 1
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 0
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 4
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 12
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year 1991
Number of shared co-authors 0
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 2
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 5
The Institute of Cancer Research
Career Start Year 1988
Number of shared co-authors 1

Collaborators

Center for Cancer Research, National Cancer Institute
Co-authored papers 23
National Cancer Institute, National Institutes of Health
Co-authored papers 21
National Center for Advancing Translational Sciences
Co-authored papers 9
National Cancer Institute, National Institutes of Health
Co-authored papers 8
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 7
Universita` degli Studi di Milano
Co-authored papers 7
Human Phenome Institute and Shanghai Cancer Center, Fudan University
Co-authored papers 7
National Institutes of Health, National Center for Advancing Translational Sciences
Co-authored papers 5
Vertex Pharmaceuticals
Co-authored papers 5
Institute for Biomedical Research August Pi I Sunyer
Co-authored papers 5
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 4
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Universita degli Studi di Milano
Co-authored papers 2
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
National Cancer Institute, Center for Cancer Research
Co-authored papers 2
Max Planck Institute for Multidisciplinary Sciences
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Co-authored papers 1
National Institute of Allergy and Infectious Diseases
Co-authored papers 1
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Co-authored papers 1
University of California Los Angeles
Co-authored papers 1
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 1
Universita di Torino
Co-authored papers 1
Lewis Sigler Institute for Integrative Genomics, Princeton University
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
Co-authored papers 1
Dana-Farber Cancer Institute
Co-authored papers 1